Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy
Fudan University
Fudan University
Ludwig-Maximilians - University of Munich
Hospital Israelita Albert Einstein
GERCOR - Multidisciplinary Oncology Cooperative Group
Tianjin Medical University Cancer Institute and Hospital
Nanfang Hospital, Southern Medical University
Qilu Pharmaceutical Co., Ltd.
National Cancer Institute, Naples
Sixth Affiliated Hospital, Sun Yat-sen University
Tanta University
NSABP Foundation Inc
Alliance for Clinical Trials in Oncology
China Medical University, China
Microbio Co Ltd
Benaroya Research Institute
ChineseAMS
Peking University Cancer Hospital & Institute
Gruppo Oncologico del Nord-Ovest
Technische Universität Dresden
China Medical University, China
University of Birmingham
National Cheng-Kung University Hospital
Hellenic Oncology Research Group
Sun Yat-sen University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
The First People's Hospital of Changzhou
Sixth Affiliated Hospital, Sun Yat-sen University
NSABP Foundation Inc
Japan Clinical Cancer Research Organization
Sixth Affiliated Hospital, Sun Yat-sen University
Sun Yat-sen University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Association pour la Recherche sur le Temps Biologique et la Chronothérapie
Fudan University
ChineseAMS
University of Southampton
ChineseAMS
Sun Yat-sen University
King Faisal Specialist Hospital & Research Center
Radboud University Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Royal Marsden NHS Foundation Trust
Arbeitsgruppe Lebermetastasen und Tumoren
Nanjing Medical University
Guangdong Provincial People's Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)